Marc O’Reilly
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Metabolism, Diabetes, and Cancer
- Protein Structure and Dynamics
- Mitochondrial Function and Pathology
Papers in
-
- Protein Degradation and Inhibitors 3
- Protein Structure and Dynamics 3
- Melanoma and MAPK Pathways 3
-
- Enzyme Structure and Function 7
- Co-authors
- L.N. Johnson (3 shared papers)Finn P. Holding (3 shared papers)Agnés C. L. Martin (1 shared paper)Barbara Chaneton (1 shared paper)Joseph E. Coyle (1 shared paper)Karen H. Vousden (1 shared paper)Liang Zheng (1 shared paper)Oliver D.K. Maddocks (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Structure (2 papers)Current Opinion in Structural Biology (2 papers)Molecular Cancer Therapeutics (2 papers)Drug Discovery Today Technologies (1 paper)
- Partner nations
- United KingdomNetherlandsSweden
In The Last Decade
Marc O’Reilly
20 papers receiving 1.3k citations
Marc O’Reilly's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 359
- Molecular Biology 989
- Biochemistry 79
- Computational Theory and Mathematics 154
- Oncology 204
Countries citing papers authored by Marc O’Reilly
This map shows the geographic impact of Marc O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc O’Reilly more than expected).
Fields of papers citing papers by Marc O’Reilly
This network shows the impact of papers produced by Marc O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc O’Reilly. The network helps show where Marc O’Reilly may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc O’Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Serine is a natural ligand and allosteric activator of pyruvate kinase M2 Hit paper breakdown → | 2012 | 510 |
| 2 | 2009 | 179 | |
| 3 | 2004 | 147 | |
| 4 | 1996 | 91 | |
| 5 | 2019 | 67 | |
| 6 | 2013 | 56 | |
| 7 | 1997 | 54 | |
| 8 | 1999 | 49 | |
| 9 | 1992 | 48 | |
| 10 | 2000 | 39 | |
| 11 | 1999 | 24 | |
| 12 | 2022 | 19 | |
| 13 | 2019 | 18 | |
| 14 | 2016 | 18 | |
| 15 | 2014 | 14 | |
| 16 | 2018 | 10 | |
| 17 | 2017 | 5 | |
| 18 | 2006 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 2 |
About Marc O’Reilly
Marc O’Reilly is a scholar working on Molecular Biology, Materials Chemistry, Computational Theory and Mathematics, Cancer Research and Organic Chemistry, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Enzyme Structure and Function (7 papers), Computational Drug Discovery Methods (4 papers), Protein Degradation and Inhibitors (3 papers), Protein Structure and Dynamics (3 papers), Melanoma and MAPK Pathways (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Click Chemistry and Applications (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (359 citations), Molecular Biology (989 citations), Biochemistry (79 citations), Computational Theory and Mathematics (154 citations) and Oncology (204 citations). Marc O’Reilly has collaborated with scholars based in United Kingdom, Netherlands and Sweden. Frequent co-authors include L.N. Johnson, Finn P. Holding, Agnés C. L. Martin, Barbara Chaneton, Joseph E. Coyle, Karen H. Vousden, Liang Zheng, Oliver D.K. Maddocks, Andris Jankevics and Achuthanunni Chokkathukalam. Their work appears in journals such as Journal of Medicinal Chemistry, Structure, Current Opinion in Structural Biology, Molecular Cancer Therapeutics and Drug Discovery Today Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.